ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up

Jack Cuzick JACK CUZICK, Wolfson Institute of Preventive Medicine, London New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued … Continue reading ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up